| [1] |
中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志，2021，42(11)：881-888.
|
| [2] |
Rodger MA, Paidas M, Mclintock C, et al. Erratum: inherited thrombophilia and pregnancy complications revisited [J]. Obstet Gynecol，2008，112(2 Pt 1)：320-324.
|
| [3] |
Facco F, You W, Grobman W. Genetic thrombophilias and intrauterine growth restriction: a meta-analysis [J]. Obstet Gynecol，2009，113(6)：1206-1216.
|
| [4] |
Infante-Rivard C, Rivard GE, Yotov WV, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction [J]. N Engl J Med，2002，347(1)：19-25.
|
| [5] |
Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus [J]. Obstetrics & Gynecology，2005，106(3)：517-524.
|
| [6] |
Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women [J]. Obstetrics & Gynecology，2010，115(1)：5-13.
|
| [7] |
Murphy RP, Donoghue C, Nallen RJ, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy [J]. Arterioscler Thromb Vasc Biol，2000，20(1)：266-270.
|
| [8] |
Clark P, Walker ID, Govan L, et al. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO (H) blood groups on haemorrhagic and thrombotic pregnancy outcomes [J]. Br J Haematol，2008，140(2)：236-240.
|
| [9] |
Lindqvist PG, Svensson PJ, Maršál K, et al. Activated protein C resistance (FV: Q506) and pregnancy [J]. Thromb Haemost，1999，81(4)：532-537.
|
| [10] |
Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications [J]. Obstetrics and Gynecology，2010，115(1)：1-7.
|
| [11] |
Bundhun PK, Soogund MZS, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001–2016 [J]．J Autoimmun，2017，79：17-27.
|
| [12] |
中华医学会围产医学分会胎儿医学学组，中华医学会妇产科学分会产科学组. 胎儿生长受限专家共识(2019版) [J]．中国产前诊断杂志(电子版)，2019，11(4)：78-98.
|
| [13] |
Fetal Growth Restriction: ACOG practice bulletin, number 227 [J]. Obstet Gynecol，2021，137(2)：e16-e28.
|
| [14] |
American College of Obstetricians and Gynecologists. ACOG practice bulletin NO.197: inherited thrombophilias in pregnancy [J]. Obstet Gynecol，2018，132(1)：e18-e34.
|
| [15] |
Andreoli L, Bertsias GK, Agmon-Levin N, et al. EULAR recommendations for women′s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome [J]. Ann Rheum Dis, 2017，76(3)：476-485.
|
| [16] |
中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识[J]. 中华围产医学杂志，2020，23(8)：517-522.
|
| [17] |
Rodger MA, Gris JC，De Vries JIP，et al.Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials[J]．Lancet，2016，388(10060)：2629-2641
|
| [18] |
Mastrolia SA, Novack L, Thachil J, et al. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia [J]. Thromb Haemost，2016，116(11)：868-878.
|